Health - Bloomberg
Skip to content
Bloomberg the Company & Its ProductsThe Company & its ProductsBloomberg Terminal Demo RequestBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg Customer SupportCustomer Support
BloombergConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
For CustomersBloomberg Anywhere Remote LoginSoftware UpdatesManage Products and Account Information
SupportAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000
CompanyAboutCareersInclusion at BloombergTech at BloombergPhilanthropySustainabilityBloomberg Beta
CommunicationsPress AnnouncementsPress Contacts
FollowFacebookInstagramLinkedInYouTube
ProductsBloomberg TerminalDataTradingRiskComplianceIndices
Industry ProductsBloomberg LawBloomberg TaxBloomberg GovernmentBloombergNEF
MediaBloomberg MarketsBloomberg TechnologyBloomberg PursuitsBloomberg PoliticsBloomberg OpinionBloomberg BusinessweekBloomberg Live ConferencesBloomberg RadioBloomberg TelevisionNews Bureaus
Media ServicesBloomberg Media DistributionAdvertising
CompanyAboutCareersInclusion at BloombergTech at BloombergPhilanthropySustainabilityBloomberg Beta
CommunicationsPress AnnouncementsPress Contacts
FollowFacebookInstagramLinkedInYouTube
ProductsBloomberg TerminalDataTradingRiskComplianceIndices
Industry ProductsBloomberg LawBloomberg TaxBloomberg GovernmentBloombergNEF
MediaBloomberg MarketsBloomberg TechnologyBloomberg PursuitsBloomberg PoliticsBloomberg OpinionBloomberg BusinessweekBloomberg Live ConferencesBloomberg RadioBloomberg TelevisionNews Bureaus
Media ServicesBloomberg Media DistributionAdvertising
BloombergConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
For CustomersBloomberg Anywhere Remote LoginSoftware UpdatesManage Contracts and Orders
SupportAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000
Sign InSubscribeSearchLive TVMarketsChevron DownEconomicsIndustriesTechPoliticsBusinessweekOpinionMoreChevron DownUS EditionChevron DownMenuSubscribeHealthIndustriesEnergyEntertainmentFinanceConsumerReal EstateLegalTransportationTelecomSportsSpaceMapLight Therapeutics Inc.Novo-Backed Drug Developer MapLight Therapeutics Files for IPOBloomberg OpinionBloomberg OpinionSchumer Finally Has a Plan for a Government ShutdownSix months after he caved to Republicans, the Senate minority leader has new and better tactics.By Nia-Malika Henderson, ColumnistCongress Has No Good Excuse to Keep Trading StocksEditorial BoardThis Crackdown on Drug Ads Is Long OverdueBy Lisa Jarvis, ColumnistDomestic Violence Is a Real Crime. My Mother Worked to Make It One.By Mary Ellen Klas, ColumnistSean Dong for Bloomberg BusinessweekHow Hims Became the King of Knockoff Weight-Loss DrugsBig Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no matter how risky it may be for the company.4 hr ago4 hr agoRights Groups Call for Probe of World Bank Hospital Funding5 hr ago5 hr agoMerck Wins US Approval of Easier-to-Use Version of Cancer Drug Keytruda5 hr ago5 hr agoUS Weighs Trump-Branded Website to Help Shop for Cheaper Drugs6 hr ago6 hr agoCDC Panel Ends Universal Covid Vaccine Recommendation6 hr ago6 hr agoHarvard Receives $46 Million in Restored Federal Research Money6 hr ago6 hr agoHarvard Accused by Trump Officials of Financial Instability7 hr ago7 hr agoA Key Test of RFK Jr.’s Vaccine Policy Descends Into ChaosA vote on the hepatitis B vaccine is indefinitely postponed. Plus: How Trump cuts upended a safety agency.7 hr ago7 hr agoUS Lurches Toward Shutdown as Senate Democrats Block GOP Stopgap8 hr ago8 hr agoMusk’s Neuralink Plans Speech Trial, Nonmedical Brain Implant10 hr ago10 hr agoRisky Biotech Stocks’ Recovery Hinges on Deeper Fed Rate Cuts10 hr ago10 hr agoHouse Passes GOP Funding Bill, Sets Up Senate Shutdown Showdown11 hr ago11 hr agoHarvard-Trained Judge in Cook Case Faces Supreme Court TestSean Dong for Bloomberg BusinessweekHow Hims Became the King of Knockoff Weight-Loss DrugsBig Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no matter how risky it may be for the company.HomeBTV+Market DataOpinionAudioOriginalsMagazineEventsNewsMarketsEconomicsTechnologyPoliticsGreenCryptoAIWork & LifeWealthPursuitsBusinessweekCityLabSportsEqualityManagement & WorkMarket DataStocksCommoditiesRates & BondsCurrenciesFuturesSectorsEconomic CalendarExploreNewslettersExplainersPointed News QuizThe Big TakeGraphicsSubmit a TipAbout UsTerms of ServiceDo Not Sell or Share My Personal InformationTrademarksPrivacy PolicyCareersMade in NYCAdvertiseAd ChoicesHelp©2025 Bloomberg L.P. All Rights Reserved.